최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Journal of Korean Medicine = 대한한의학회지, v.38 no.3, 2017년, pp.124 - 142
한가진 (소람한방병원) , 성신 (소람한방병원) , 김성수 (소람한방병원) , 김진성 (경희대학교 한의과대학 비계내과학 교실) , 박재우 (경희대학교 한의과대학 비계내과학 교실)
Objectives: This study aimed to learn what should be considered in [Guideline of Clinical Trial with Herbal Medicinal Product for Gastric Cancer)] by analyzing the existing guidelines and clinical trials. Methods: The development committee searched guidelines for herbal medicinal product or gastric ...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
핵심어 | 질문 | 논문에서 추출한 답변 |
---|---|---|
위암의 종류에는 어떠한 것들이 있는가? | 위암의 종류로는 위점막의 선세포에서 발생한 위선암이 가장 많고, 림프종, 간질성 종양, 육종, 신경내분비암 등이 있다2). 위암의 치료로는 수술, 방사선 요법, 항암화학요법3), 분자표적치료4)등이 행해지고 있으나, 완치율이 낮고 치료과정의 부작용 등으로 인해 암환자 및 가족들은 신체적, 정신적, 사회경제적으로 심한 부담을 안고 있는 것이 현실이다5). | |
한국에서 성별에 따른 위암 발생률은 어떠한가? | 위암은 2014년 국가암등록통계에 따르면 국내에서 갑상선암에 이어 두 번째로 많이 발생한 암으로, 남자에서는 전체 암 중 발생률이 17.8%로 1위이며, 여자에서는 9.4%로 4위를 차지하고 있다. 암발생과 암생존의 영향을 하나로 종합하여 암의 부담을 나타내는 지표인 암유병률에서도 2위를 차지하였는데, 이는 진단받은 후 5년이 경과해도 여전히 암으로 인해 계속 고통을 받고 있다는 의미이다1). | |
위암의 암유병률은 2위인데 이것이 시사하는 의미는 무엇인가? | 4%로 4위를 차지하고 있다. 암발생과 암생존의 영향을 하나로 종합하여 암의 부담을 나타내는 지표인 암유병률에서도 2위를 차지하였는데, 이는 진단받은 후 5년이 경과해도 여전히 암으로 인해 계속 고통을 받고 있다는 의미이다1). |
Ministry of Health and Welfare. National Cancer Registration Statistics Reference 2014. 2016.12.20.
National Cancer Information Center. Gastric Cancer 2014. Avaliable at: URL:http://www.cancer.go.kr/mbs/cancer/index.jsp.
Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, et al. Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach. Korean J Gastroenterol. 2014;63(2):66-81.
Cheung DY, Kim JK. Perspectives of the Stomach Cancer Treatment: The Introduction of Molecular Targeted Therapy and the Hope for Cure. Korean J Gastroenterol. 2013;61(3):117-27.
SB Jang, et al. A Study on Complementary Alternative Therapy Used by Cancer Patients in Korea. Korean J Adult Nurs. 2006;18(1):92-101.
Lee Ei, Shin YC, Lee JH, Kim SD, Kim HJ, Cho MS. Use of Complementary and Alternative Medicine in Cancer Patients at 7 General Hospitals in Seoul. J Korea Public Health Assoc. 2002;28(3): 225-38.
Ha TH, Seong S, Lee DH, Kim SS. Improved Case of Recurred and Metastatic Ascending Colon Cancer by Combination of Oriental Medical Therapy and FOLFIRI Chemotherapy. Korean J Oriental Physiology & Pathology. 2013;26(1):148-51.
Cheon SH, Kim KS, Kim S, Jung HS, Choi WC, Eo WK. Efficacy and Safety of Rhus verniciflua Stokes Extracts in Patients with Previously Treated Advanced Non-Small Cell Lung Cancer. Forsch Komplementmed. 2011;18(2):77-83.
Kim BJ, Moon G. An Outlook of the Oriental and Western Medical Diagnosis and Treatment on Gastric Cancer. KOMS. 1996;17(2):100-16.
Hwang CY. Bibliographic Study on the Therapy of Gastric Cancer by Intergrated Oriental and Western Medicine. The Journal of Wonkwang Oriental Medicine. 1997;7(1):10-8.
Jung JH, Seo JC, Kwak MA, Sohn KC. Literature Review on Traditional Chinese Medicine Treatment of Gastric Cancer. J Int Korean Med. 2014;35(3):332-42.
Sim BS, Choi SH. A Literatural Study on Pattern Identification Type of Stomach Cancer. J of Oriental Medical Pathology. 1993;8:295-303.
Nationwide Medical College of Oriental Gastroenterology Medicine. Oriental Gastroenterology. Seoul: Koonja Publisher Co. 2008:126-36.
Korea Health Industry Development Institute. Clinical trial status and prospect of domestic drug. Seoul: Korea Health Industry Development Institute. 2006:7-14.
Kim HR, Yoo HS, Beak DG, Park IH, Jang CY, Kim HY. Clinical Practice Guidelines in Korean Medicine for Gastric Cancer. Korean J Orient Int Med. 2016;37(1);25-46.
Kim SH, Namgung MA, Chang YS, Jeong SK, Kim JS, Yoon SW, et al. Study on Development of Assessment Guideline and Endpoints for Clinical Trial with Antitumor Natural Products. Korean J Oriental Physiology & Pathology. 2006;20(6):1678-1727.
National Institute of Food and Drug Safety Evaluation. Guidelines for clinical trial of anticancer drugs. 2015.12
National Institute of Food and Drug Safety Evaluation. Guidelines for non-clinical trial of anticancer drugs. 2015.12
Ministry of Food and Drug Safety. Guideline for evaluation of clinical trial of anticancer drugs.
National Institute of Food and Drug Safety Evaluation. Guidelines for Exemption of Anticancer Drug Data in Bridging Study. 2015.07.
Ministry of Food and Drug Safety. General considerations in clinical trials of herbal medicine preparations. Seoul:Ministry of Food and Drug Safety. 2007.
Korean Institution of Oriental Medicine. A study on the clinical trial guidelines of herbal medicinal drug. Seoul:Ministry of Food and Drug Safety. 2004.
Industry-Academia Collaboration Foundation, Kyung Hee University. Research on outcome indicators for clinical trials of herbal medicinal products. Seoul:Ministry of Food and Drug Safety. 2006.
Yoshikawa K, Shimada M, Wakabayashi G, Ishida K, Kaiho T, Kitagawa Y,et al. Effect of Daikenchuto, a Traditional Japanese Herbal Medicine, after Total Gastrectomy for Gastric Cancer: A Multicenter, Randomized, Double -Blind, Placebo-Controlled, Phase II Trial. J Am Coll Surg. 2015;221(2):571-8.
Takahashi T, Endo S, Nakajima K, Souma Y, Nishida T. Effect of rikkunshito, a chinese herbal medicine, on stasis in patients after pylorus-preserving gastrectomy. World J Surg. 2009;33(2):296-302.
Akamaru Y, Takahashi T, Nishida T, Omori T, Nishikawa K, Mikata S, et al. Effects of daikenchuto, a Japanese herb, on intestinal motility after total gastrectomy: a prospective randomized trial. J Gastrointest Surg. 2015;19(3):467-72.
Wang HZ, Wang HB, Gao H. Clinical observation on treatment of 34 advanced gastric carcinoma patients by chemotherapy of DCF regimen combined with Fuzheng Hewei Decoction. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2007;27(10):927-9.
Yin SH, Du YQ, Liu B. Clinical study on acupuncture combined with medication in restoration of gastrointestinal functions for postoperative patients with gastric cancer. Zhongguo Zhen Jiu. 2009;29(6):459-62.
Wang H, Guo LJ, Wu B. Effect of rhubarb combined with enteral nutrition on C-reactive protein and interleukin-6 in peripheral blood of patients with gastric cancer during perioperative period. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(2):101-4.
Cai J, Wang H, Zhou S, Wu B, Song HR, Xuan ZR. Effect of Sijunzi Decoction and enteral nutrition on T-cell subsets and nutritional status in patients with gastric cancer after operation: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao. 2008;6(1):37-40.
Wang Y, Wang YT, Lin YH, Zou ZD. Effects of Xuesaitong injection on coagulation function of gastric cancer patients undergoing laparoscopic surgery: a randomized controlled trial. Zhong Xi Yi Jie He Xue Bao. 2009;7(6):514-7.
Huang CX, Chen LZ, Zhao JG. Influence of chemotherapy with FOLFOX protocol on sex hormones of male patients and the protective effect of herbal medicines for reinforcing Shen and supplementing qi on it. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2008;28(11):986-9.
Sun DZ, Jiao JP, Zhang X, Xu JY, Ye M, Xiu LJ, et al. Therapeutic effect of Jinlongshe Granule on quality of life of stage IV gastric cancer patients using EORTC QLQ-C30: A double-blind placebo-controlled clinical trial. Chin J Integr Med. 2015;21(8):579-86.
Cheon CH, Park SJ, Jang BH, Shin YC, Ko SG. The Analysis of usage of Symptom Differentiation in Clinical Trials in Korean Medicine for Cancer Patients. spkom. 2015:19(1):61-70.
Lyseng-Williamson KA, Fenton C. Docetaxel: a review of its use in metastatic breast cancer. Drugs. 2005;65(17):2513-31.
Jeong TY, Lee YW, Cho JG, Yoo HS. Analysis of Clinical Characteristics for 899 Cancer Patients Treated at an Oriental Hospital. Korean J Orient Int Med. 2010;31(1):102-12.
Lin H. Guidelines of Diagnosis and Therapy in Oncology with Traditional Chinese Medicine. Beijing: Renminweisheng Press; 2014, p. 306-38.
Lee JI, Shim KY, Kim HY, Choi SY, Bang DG, Cho KS. Clinical Study of the Efficacy of Combined Western-Oriental Medicine for Gastric Cancer and Hepatocellular Carcinoma. J of Kor Traditional Oncology. 2001;7(1):117-129.
Lee JH, Kim JG, Jung HK, Kim JH, Jeong WK, Jeon TJ, et al. Synopsis on Clinical Practice Guideline of Gastric Cancer in Korea: An Evidence-Based Approach, Korean J Gastroenterol. 2014;63(2):66-81.
Kong KH, Ha J, Baek TH. One Case on Diagnosis and Treatment Based on an Overall Analysis of Signs and Symtoms of Stomach Cancer stage IV. Korean J Orient Int Med. 2000;21(5):897-902.
Sim BS, Choi SH. A Literatural Study on Pattern Identification Type of Stomach Cancer. J of Oriental Medical Pathology. 1993;8:295-303.
Hwang SY, Ahn SH, Keum KS. Proposal on Supplementation to Oriental Medical Policy for the Revitalization of Oriental Medical Therapy for Stomach Cancer. Korean J Oriental Physiology & Pathology. 2009;23(3):528-33.
Nationwide Medical College of Oriental Gastroenterology Medicine. Oriental Gastroenterology. Seoul:Koonja Publisher Co. 2008:126-36.
Lee NH, Cho JH, Son CG, Yoo HS, Lee YW, Yoon DH, et al. Analysis of Studies on Quality of Life according to Cancer Types and Symptoms. Korean J Orient Int Med. 2006:27(3):555-60.
Lee EH, Park HB, Kim MW, Kang SH, Lee HJ, Lee WH, et al. Analyses of the Studies on Cancer-Related Quality of Life Published in Korea. Radiat Oncol J. 2002.29(4):359-66.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.